Miscarriage and abortion

Published on 10/03/2015 by admin

Filed under Obstetrics & Gynecology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4452 times

Chapter 11 Miscarriage and abortion

Abortion or miscarriage is defined as the expulsion of a fetus before it reaches viability. Because of different definitions of viability in different countries, the World Health Organization (WHO) has recommended that a fetus is considered potentially viable when the gestation period has reached 22 weeks or more, or when the fetus weighs 500 g or more. As the term abortion does not differentiate between spontaneous and induced abortion the term miscarriage is widely preferred, abortion being used when the pregnancy is deliberately terminated before fetal viability. Most miscarriages occur naturally between the sixth and 10th weeks of pregnancy.

Data from several countries estimate that between 10 and 20% of clinically diagnosed pregnancies end in miscarriage. Miscarriage is more frequent among women over the age of 30 and increases further among women over the age of 35; the risk being nine times greater than for women aged 20–29. Paternal age over 40 also increases the risk, albeit not as strongly as maternal age. The risk also increases in frequency with increasing gravidity: 6% of first or second pregnancies terminate as a miscarriage; with third and subsequent pregnancies the rate increases to 16%.

AETIOLOGY OF SPONTANEOUS MISCARRIAGE

The causes of miscarriage are:

MECHANISMS OF MISCARRIAGE

The immediate cause of miscarriage is the partial or complete detachment of the embryo by minute haemorrhages in the decidua. As placental function fails uterine contractions begin, and the process of miscarriage is initiated. If this occurs before the eighth week the defective embryo, covered with villi and some decidua, tends to be expelled en masse (the so-called blighted ovum), although some of the products of conception may be retained either in the cavity of the uterus or in the cervix. Uterine bleeding occurs during the expulsion process.

Between the eighth and 14th weeks the above mechanism may occur or the membranes may rupture, expelling the defective fetus but failing to expel the placenta, which may protrude through the external cervical os or remain attached to the uterine wall. This type of miscarriage may be attended by considerable haemorrhage.

Between the 14th and 22nd weeks the fetus is usually expelled followed, after an interval, by the placenta. Less commonly the placenta is retained. Usually bleeding is not severe, but pain may be considerable and resemble a miniature labour.

It is clear from this description that miscarriage is attended by uterine bleeding and pain, both of varying intensity. Although miscarriage is the cause of bleeding per vaginam in early pregnancy in over 95% of cases, less common causes, such as ectopic gestation, cervical bleeding from the everted cervical epithelium or from an endocervical polyp, hydatidiform mole, and, rarely, cervical carcinoma, must be excluded.

VARIETIES OF SPONTANEOUS MISCARRIAGE

For descriptive purposes the miscarriage is classified according to the findings when the woman is first examined, but one kind may change into another if the aborting process continues. If infection complicates the miscarriage, the term septic miscarriage is used. The various types of miscarriage are shown in Figure 11.1 and each will be considered separately later.

Inevitable, incomplete and complete miscarriage

Miscarriage becomes inevitable if uterine bleeding is associated with strong uterine contractions that cause dilatation of the cervix. The woman complains of severe colicky uterine pains, and a vaginal examination shows a dilated cervical os with part of the conception sac bulging through. Inevitable miscarriage may follow signs of threatened miscarriage or, more commonly, starts without warning.

Soon after the onset of symptoms of inevitable miscarriage, the miscarriage occurs either completely, when all the products of conception are expelled, or incompletely when either the pregnancy sac or the placenta remains, distending the cervical canal. In most cases the miscarriage is incomplete. Unless the doctor has been able to inspect all the material expelled from the uterus, or has had an ultrasound examination that shows an empty uterus (or one containing less than 10 mm of tissues or blood clots), the miscarriage should be considered incomplete. This is treated by curettage; an alternative is to give misoprostol 400 μg 4-hourly for three doses or 800 μg as a single dose which will achieve a 60–80% complete evacuation of the uterus.

Septic miscarriage

Although less common than formerly, because of better care in hospital and fewer ‘backyard’ abortions, infection may complicate some spontaneous and induced abortions. In 80% of cases the infection is mild and localized to the decidua. The organisms involved are usually endogenous and are, most commonly, anaerobic streptococci, staphylococci or Escherichia coli. In 15% of cases the infection is severe, involving the myometrium, and may spread to involve the Fallopian tubes. If the infection spreads from the cervix it may involve the parametrium or the pelvic cellular tissues. In 5% of cases there is generalized peritonitis or vascular collapse, which is due to the release of endotoxins by E. coli or Clostridium welchii and is termed endotoxic shock.

Missed miscarriage/abortion

In a few cases of miscarriage the dead embryo or fetus and placenta are not expelled spontaneously. If the embryo dies in the early weeks it is likely to be anembryonic or blighted. In other cases a fetus forms but dies. Multiple haemorrhages may occur in the choriodecidual space, which bulge into the empty amniotic sac. This condition is called a carnaceous mole. It is thought that although the fetus has died, progesterone continues to be secreted by surviving placental tissue, which delays the expulsion of the products of conception (Fig. 11.3).

If the fetus dies at a later stage of the pregnancy, but before the 22nd gestational week, and is not expelled, it is either absorbed or mummified. The liquor amnii is absorbed and the placenta degenerates. Fetal death after the 22nd week is discussed on page 203.

Recurrent (habitual) miscarriage

A few women (1%) have the misfortune to miscarry successively. It has been estimated that after one miscarriage the risk of another is 20%; after two miscarriages it is 25%. If the woman has not had a previous liveborn infant after three miscarriages the chances of achieving a successful pregnancy outcome is 55–60%, but is 70% if she has had one or more liveborn. A woman who has three or more successive miscarriages is termed a recurrent miscarrier.

The aetiological factors in recurrent miscarriage vary depending on the population studied, but two large series, of over 100 subjects in each, offer some idea of the aetiology (Table 11.2). In Table 11.2 the causes marked with a query are speculative.

Table 11.2 Recurrent miscarriage

POSSIBLE AETIOLOGY PERCENTAGE OF MISCARRIAGES OCCURRING
  <12 weeks >12 weeks
Not known 62 35
Uterine malformations or abnormality 3 10
Cervical incompetence 3 30
Chromosome abnormality <5 <4
?Endometrial infection 15 15
Endocrine dysfunction 3 3
Systemic disease 1 1
?Sperm factors 3 1
?Immune factors ? 1

Investigation and treatment of a recurrent miscarrier

A careful medical and obstetric history may reveal systemic disease or suggest cervical incompetence. A vaginal examination may show uterine myomata or cervical incompetence, and the diagnosis can be clarified if a transvaginal ultrasound image is made. Ultrasound will also detect uterine malformations. Submucous myomata or uterine septa may be removed by abdominal surgery or under hysteroscopic vision. Cervical incompetence is discussed later.

If endometrial infection is considered a causative factor (as is the case with some specialists), endometrial tissue cultures may be made. However, it is doubtful whether toxoplasmosis, cytomegalovirus, herpes virus, rubella or listeria are causes of recurrent miscarriage.

Endocrine dysfunctions, for example polycystic ovarian disease (see p. 223), may be excluded by transvaginal ultrasound scanning and blood tests. Other endocrine disorders, such as thyroid disease and diabetes, are no longer believed to be causes of recurrent miscarriage unless they are poorly controlled.

Although it is usual to investigate both parents for chromosome abnormalities, such aberrations account for only 5% of recurrent miscarriages at the most, and no treatment is available apart from donor gametes.

Immunological causes for recurrent miscarriage have been sought. The theory is that if the two parents share several human leucocyte antigen (HLA) sites the fetus may not be able to provide a sufficient stimulus to enable the mother to produce blocking antibodies to the allogenic fetus, with the result that the fetus is aborted. However, clinical trials that entail immunizing the woman between pregnancies with paternal leucocytes, pooled donor cells or trophoblast membrane preparations to enhance her immune system, have failed to show any benefit.

A few women with an autoimmune disease, especially the antiphospholipid syndrome and systemic lupus erythematosus (SLE), have a strong blocking antibody reaction which, it is believed, may lead to recurrent miscarriage. SLE must be excluded before immunotherapy is used as SLE may be aggravated. If SLE is identified by laboratory tests, treatment with low-dose aspirin and low-dose heparin improves the live birth rate from 10% to 70%.

Cervical incompetence

About 20% of women who have recurrent miscarriages in the second quarter of pregnancy will be found to have cervical incompetence. The diagnosis is based on:

If cervical incompetence is diagnosed, treatment entails placing a soft unabsorbable suture (such as Mersilk 4) around the cervix at the level of the internal cervical os (Fig. 11.4). The patient may return home the same night or stay in hospital for a day, depending on the circumstances. There is no place postoperatively for the use of progesterone, uterine relaxants or narcotics. If there is doubt about the diagnosis, then surveillance with ultrasound is undertaken, cerclage being performed if there are signs of cervical shortening and/or beaking of the membranes through the internal os.

Following cervical cerclage 10% of women abort, 10% give birth prematurely, and the remainder give birth after the 36th week of pregnancy. Cervical cerclage should not be performed if the membranes have ruptured. If miscarriage or premature rupture of the membranes occurs or premature delivery becomes inevitable following cerclage, the suture must be cut. In all other cases the suture is left until about 7 days prior to term, at which time it is cut, and the woman may then be expected to give birth vaginally.

INDUCED ABORTION

In many countries induced (therapeutic) abortion is now legal. The exact conditions vary, but the purposes of legalizing abortion are:

The main reasons for abortion are shown in Box 11.1. In most developed countries where abortion is legal, over 95% are performed for social or psychiatric reasons. It should be stressed that women rarely seek an abortion without considerable thought, and are receptive to and welcome counselling during this difficult time. It is also evident that in many cases the pregnancy could have been prevented if effective contraceptive precautions had been taken.

Technique of induced abortion

Abortion is safest when it is performed between the sixth and 12th gestational weeks. Only between 5 and 10% of terminations are made after the 12th week of pregnancy. Termination of the pregnancy may be surgical or medical.

The surgical approach is to evacuate the uterus using a suction curette, under local or general anaesthesia. Following curettage uterine bleeding persists for about 6 days, often being light in the first 2 days after the termination. Most gynaecologists give the woman a course of doxycycline to prevent infection.

Medical methods of termination can be used if the pregnancy is less than 9 weeks’ gestation. These include the administration of a single dose of the progesterone antagonist mifepristone (200–600 mg). The mifepristone tablet is followed 36–48 hours later by a prostaglandin E1 vaginal pessary (gemeprost) 1 mg every 6 hours for four doses. If the abortion has not started within 24 hours, gemeprost 1 mg is given 3-hourly for up to four more doses. (An alternative is oral misoprostol 200 μg repeated after 2 hours.) Bleeding usually starts during the interval between the mifepristone and the gemeprost vaginal pessary or oral misoprostol, and uterine contractions start within 4 hours of the administration of either drug. The pain may be severe and most women require narcotics. Nausea or vomiting affects one-third of patients. Bleeding persists for about 9 days, with a mean loss of 75 mL (20–400 mL). Over 98% of women abort using this regimen, but 10% require curettage for persistent heavy bleeding.

In countries where mifepristone is not available two commonly used drugs may be prescribed. Methotrexate 50 mg/m2 body surface is given intramuscularly. This prevents folate from entering the fetal tissues, with resultant death. Misoprostol 800 μg is given intravaginally 5–7 days later, and following this 75% of women abort within 24 hours. If the abortion does not occur, the misoprostol is repeated.

After the 12th gestational week the uterus may be evacuated using the following:

These regimens induce an abortion in 80–95% of patients and may replace dilatation of the cervix and uterine evacuation using sponge forceps and a curette, which can be a bloody and prolonged procedure.

Over 80% of women require narcotics for pain, and nausea or vomiting occurs in 30%. Following the abortion, one-third of women require evacuation of the uterus for retained products of conception.